As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. Recent clinical trials and global ...

We also provide primary care and referrals for HIV treatment to optimize the health and wellness of people living with HIV/AIDS. You can obtain information about HIV testing from your medical provider ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

With new treatments and methods of preventing HIV/AIDS discovered each decade, it is likely that a treatment with potential to cure the virus or enact long-term prevention could reduce the number ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

It continues to maintain its dominant position with an increasing market share for treatment and prevention. Gilead projects HIV sales to grow 4% in 2024. Lenacapavir is already approved under the ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

Centers for Disease Control and Prevention. Preventing HIV with Condoms. What I Wish I Knew About How Much HIV Treatment Would Progress What I Wish I Knew About the Community I’d Have After My ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

treatment, care and support for HIV and AIDS, including nutrition and linkages with reproductive health ARV = Antiretroviral therapy; MTCT = Mother-to-child transmission; PMTCT = Prevention of ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...